Defense Health Agency Contracting Activity - DHACA
DoW Toxic Exposures Clinical Trial Award
DoW Toxic Exposures Clinical Trial Award is a funding opportunity from Defense Health Agency Contracting Activity - DHACA, closing November 19, 2026.
Overview
Summary: The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases or conditions…